Key Points
- Insider sold 309,902 shares — Bar Veinstein sold 309,902 Clarivate (CLVT) shares on Dec. 1 at an average $3.74 for about $1.16 million, trimming his stake by 26.75% to 848,811 shares.
- Clarivate trades near its 52-week low (range $3.04–$5.86, opened $3.69), has a $2.44 billion market cap and a negative P/E, and carries a consensus analyst rating of "Reduce" with an average price target of $4.90.
Clarivate PLC (NYSE:CLVT - Get Free Report) insider Bar Veinstein sold 309,902 shares of the stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $3.74, for a total value of $1,159,033.48. Following the completion of the transaction, the insider owned 848,811 shares of the company's stock, valued at $3,174,553.14. The trade was a 26.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Clarivate Price Performance
NYSE:CLVT opened at $3.69 on Wednesday. Clarivate PLC has a 52 week low of $3.04 and a 52 week high of $5.86. The stock's fifty day moving average is $3.60 and its two-hundred day moving average is $4.02. The company has a market capitalization of $2.44 billion, a P/E ratio of -6.46 and a beta of 1.51. The company has a quick ratio of 0.87, a current ratio of 0.87 and a debt-to-equity ratio of 0.90.
Analysts Set New Price Targets
A number of research analysts have commented on the stock. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Clarivate in a research report on Monday. Wolfe Research began coverage on shares of Clarivate in a research note on Wednesday, September 3rd. They issued a "peer perform" rating on the stock. Finally, The Goldman Sachs Group set a $4.20 price objective on shares of Clarivate in a research report on Thursday, October 30th. Three analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Reduce" and a consensus price target of $4.90.
Check Out Our Latest Stock Report on Clarivate
Institutional Trading of Clarivate
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC lifted its position in shares of Clarivate by 688.8% during the second quarter. Parallel Advisors LLC now owns 8,196 shares of the company's stock worth $35,000 after purchasing an additional 7,157 shares in the last quarter. Essex Financial Services Inc. purchased a new stake in Clarivate during the 3rd quarter worth approximately $41,000. PharVision Advisers LLC acquired a new stake in Clarivate during the 3rd quarter worth approximately $45,000. Ground Swell Capital LLC acquired a new stake in Clarivate during the 3rd quarter worth approximately $47,000. Finally, 111 Capital purchased a new position in Clarivate in the 3rd quarter valued at approximately $48,000. 85.72% of the stock is currently owned by hedge funds and other institutional investors.
Clarivate Company Profile
(
Get Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
